Stephen Becker

1.3k total citations
33 papers, 974 citations indexed

About

Stephen Becker is a scholar working on Infectious Diseases, Virology and Oncology. According to data from OpenAlex, Stephen Becker has authored 33 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 21 papers in Virology and 5 papers in Oncology. Recurrent topics in Stephen Becker's work include HIV/AIDS drug development and treatment (22 papers), HIV Research and Treatment (21 papers) and HIV/AIDS Research and Interventions (16 papers). Stephen Becker is often cited by papers focused on HIV/AIDS drug development and treatment (22 papers), HIV Research and Treatment (21 papers) and HIV/AIDS Research and Interventions (16 papers). Stephen Becker collaborates with scholars based in United States, United Kingdom and Denmark. Stephen Becker's co-authors include Ron MacFarland, Christopher M. Dezii, Marta Boffito, Gary Calandra, Corklin Steinhart, Daniel Berger, Dion F. Coakley, Andrew Cheng, Gerald Pierone and Gregory Fusco and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Stephen Becker

31 papers receiving 926 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Becker United States 18 654 440 199 169 164 33 974
Christina M. Lalama United States 17 765 1.2× 862 2.0× 178 0.9× 188 1.1× 194 1.2× 36 1.2k
Lucia Palmisano Italy 24 1.1k 1.6× 930 2.1× 295 1.5× 154 0.9× 234 1.4× 74 1.7k
Peter Gute Germany 18 868 1.3× 688 1.6× 308 1.5× 56 0.3× 216 1.3× 35 1.2k
Paola Meraviglia Italy 19 941 1.4× 556 1.3× 368 1.8× 141 0.8× 330 2.0× 61 1.3k
Giuliano Rizzardini Italy 15 800 1.2× 539 1.2× 341 1.7× 62 0.4× 286 1.7× 39 1.3k
Bobbie Graham United States 13 440 0.7× 314 0.7× 206 1.0× 372 2.2× 97 0.6× 24 1.0k
Michael Wohlfeiler United States 14 758 1.2× 637 1.4× 280 1.4× 107 0.6× 209 1.3× 31 1.1k
Martin S. Hirsch United States 7 1.2k 1.9× 1.1k 2.5× 458 2.3× 95 0.6× 130 0.8× 7 1.6k
Henry H. Balfour United States 7 780 1.2× 575 1.3× 495 2.5× 72 0.4× 86 0.5× 7 1.2k
Carla Pettinelli United States 9 1.4k 2.1× 1.0k 2.3× 655 3.3× 100 0.6× 163 1.0× 11 1.8k

Countries citing papers authored by Stephen Becker

Since Specialization
Citations

This map shows the geographic impact of Stephen Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Becker more than expected).

Fields of papers citing papers by Stephen Becker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Becker. The network helps show where Stephen Becker may publish in the future.

Co-authorship network of co-authors of Stephen Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Becker. A scholar is included among the top collaborators of Stephen Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Becker. Stephen Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ewart, Gary, Michael Bobardt, Bo Hjorth Bentzen, et al.. (2023). Post-infection treatment with the E protein inhibitor BIT225 reduces disease severity and increases survival of K18-hACE2 transgenic mice infected with a lethal dose of SARS-CoV-2. PLoS Pathogens. 19(8). e1011328–e1011328. 7 indexed citations
2.
Phillips, Andrew, Valentina Cambiano, Paul Revill, et al.. (2016). Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan Africa. The Journal of Infectious Diseases. 214(1). 73–79. 12 indexed citations
3.
Boffito, Marta, Akil Jackson, Andrew Owen, & Stephen Becker. (2013). New Approaches to Antiretroviral Drug Delivery: Challenges and Opportunities Associated with the Use of Long-Acting Injectable Agents. Drugs. 74(1). 7–13. 34 indexed citations
4.
5.
Garnett, Geoffrey P., Stephen Becker, & Stefano Bertozzi. (2012). Treatment as prevention. Current Opinion in HIV and AIDS. 7(2). 157–163. 20 indexed citations
6.
Veronese, Fulvia, Peter A. Anton, Courtney V. Fletcher, et al.. (2010). Implications of HIV PrEP Trials Results. AIDS Research and Human Retroviruses. 27(1). 81–90. 17 indexed citations
7.
Kim, Susan C., Stephen Becker, Carl W. Dieffenbach, et al.. (2010). Planning for pre‐exposure prophylaxis to prevent HIV transmission: challenges and opportunities. Journal of the International AIDS Society. 13(1). 24–24. 41 indexed citations
8.
Moyle, Graeme, Edwin DeJesus, Marta Boffito, et al.. (2009). Proof of Activity with AMD11070, an Orally Bioavailable Inhibitor of CXCR4‐Tropic HIV Type 1. Clinical Infectious Diseases. 48(6). 798–805. 60 indexed citations
9.
Nyunt, Myaing M., Stephen Becker, Ron MacFarland, et al.. (2008). Pharmacokinetic Effect of AMD070, an Oral CXCR4 Antagonist, on CYP3A4 and CYP2D6 Substrates Midazolam and Dextromethorphan in Healthy Volunteers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(5). 559–565. 19 indexed citations
10.
King, Jennifer R., et al.. (2007). Pharmacokinetics of Saquinavir With Atazanavir or Low‐Dose Ritonavir Administered Once Daily (ASPIRE I) or Twice Daily (ASPIRE II) in Seronegative Volunteers. The Journal of Clinical Pharmacology. 47(2). 201–208. 12 indexed citations
11.
Chinn, Leslie W., et al.. (2007). Interindividual variability in the effect of atazanavir and saquinavir on the expression of lymphocyte P-glycoprotein. Journal of Antimicrobial Chemotherapy. 60(1). 61–67. 7 indexed citations
12.
Cameron, D. William, Stephen Becker, Martin King, et al.. (2007). Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen. Journal of Antimicrobial Chemotherapy. 59(5). 957–963. 14 indexed citations
13.
Munakata, Julie, Joshua S. Benner, Stephen Becker, et al.. (2006). Clinical and Economic Outcomes of Nonadherence to Highly Active Antiretroviral Therapy in Patients With Human Immunodeficiency Virus. Medical Care. 44(10). 893–899. 40 indexed citations
14.
Becker, Stephen. (2004). Liver Toxicity in Epidemiological Cohorts. Clinical Infectious Diseases. 38(Supplement_2). S49–S55. 37 indexed citations
15.
Becker, Stephen, Gregory Fusco, Jennifer S Fusco, et al.. (2004). HIV‐Associated Thrombotic Microangiopathy in the Era of Highly Active Antiretroviral Therapy: An Observational Study. Clinical Infectious Diseases. 39(s5). S267–S275. 68 indexed citations
16.
Becker, Stephen. (2003). Atazanavir: improving the HIV protease inhibitor class. Expert Review of Anti-infective Therapy. 1(3). 403–413. 16 indexed citations
17.
18.
Becker, Stephen, et al.. (2001). Zidovudine and Stavudine Sequencing in HIV Treatment Planning: Findings From the CHORUS HIV Cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(1). 72–81. 23 indexed citations
19.
Becker, Stephen, Alvan Fisher, Charles Flexner, et al.. (2001). Pharmacokinetic Parameters of Protease Inhibitors and the Cmin/IC50 Ratio: Call for Consensus. JAIDS Journal of Acquired Immune Deficiency Syndromes. 27(2). 210–211. 2 indexed citations
20.
Eron, Joseph J., Peter Ruane, Stephen Becker, et al.. (2000). Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection. AIDS. 14(6). 671–681. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina M. Lalama Breakdown of academic impact, for papers by Lucia Palmisano Breakdown of academic impact, for papers by Peter Gute Breakdown of academic impact, for papers by Paola Meraviglia Breakdown of academic impact, for papers by Giuliano Rizzardini Breakdown of academic impact, for papers by Bobbie Graham Breakdown of academic impact, for papers by Michael Wohlfeiler Breakdown of academic impact, for papers by Martin S. Hirsch Breakdown of academic impact, for papers by Henry H. Balfour Breakdown of academic impact, for papers by Carla Pettinelli
Rankless by CCL
2026